In turn, more than 1 year of treatment with the β2AR blocker propranolol for cardiac disease resulted in an increased risk of PD, with 41 subjects developing PD versus the ~ 17 subjects who would be expected to develop PD. The gene discussed is ADRB2; the disease is Parkinson disease.